OPN Talks with James G. Fujimoto

Lyndsay Basista

Our conversation with James Fujimoto, OCT pioneer.



Optical coherence tomography (OCT) is a relatively new technology, but is it having a significant impact in biomedical research. It was first demonstrated just 20 years ago, and it has already emerged as a powerful imaging tool in the biomedical world. In fact, OCT has become so widespread in the medical field that a journal keyword search on "optical coherence tomography" retrieves more than 10,000 references. The commercial market is estimated at several hundred million dollars.

Log in or become a member to view the full text of this article.

This article may be available for purchase via the search at Optica Publishing Group.
Optica Members get the full text of Optics & Photonics News, plus a variety of other member benefits.

Add a Comment